Cbd Chemotypes

CBD chemotypes represent cannabis plants selectively bred to produce elevated cannabidiol (CBD) content while maintaining lower THC levels. These genetics emerged from both landrace selection and targeted crosses, particularly following early breeding work with high-CBD strains like Cannatonic, Charlotte's Web, and Harlequin. CBD chemotypes are classified by their cannabinoid ratios—commonly 1:1 (CBD:THC), 20:1, or pure CBD-dominant phenotypes—determined by specific genetic markers controlling CBDA synthase enzyme activity. Breeders working in this category often stabilize these traits across multiple generations to ensure consistent biochemical profiles. The underlying genetics involve recessive alleles that suppress THC production pathways while upregulating CBD synthesis, making outcrossing to THC-dominant stock a primary breeding consideration.

CBD chemotypes serve as foundational parent material for industrial hemp production and hybrid development. Breeders use these genetics to introduce CBD expression into novel crosses while managing THC levels for regulatory compliance, or to explore cannabinoid synergy ratios in specialty applications.